Predictive analysis of microenvironment impact on clinical outcomes to drug agents using simulation of myeloproliferative neoplasms.

Authors

null

Peter P. Sayeski

University of Florida, Gainesville, FL

Peter P. Sayeski , Shireen Vali , Ansu Kumar , Neeraj Singh , Anuj Tyagi , Taher Abbasi , Susumu Kobayashi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Leukemia, Myelodysplasia, and Transplantation

Track

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Sub Track

Myeloproliferative Neoplasms (MPN) and Mast Cell Disorders

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 7110)

DOI

10.1200/jco.2014.32.15_suppl.7110

Abstract #

7110

Poster Bd #

395

Abstract Disclosures

Similar Posters

First Author: Eleonora Teplinsky

First Author: Ciro Roberto Rinaldi

Poster

2024 ASCO Breakthrough

Molecular basis for JAK2 inhibition with type II compounds.

Molecular basis for JAK2 inhibition with type II compounds.

First Author: Dafne Jacome

Poster

2024 ASCO Annual Meeting

Outcomes of patients with bone marrow fibrosis in de novo and secondary acute myeloid leukemia.

Outcomes of patients with bone marrow fibrosis in de novo and secondary acute myeloid leukemia.

First Author: Samuel Urrutia